NBC4 New York, August 31, 2016. The CEO of Mylan Pharmaceuticals announced the launch of its own cheaper version of the EpiPen but previously fought to keep prices high by limiting options.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Part D Pricing Trends
POLITICO Prescription Pulse, August 22, 2016. Medtronic is facing allegations that it promoted a device for uses not approved by FDA. “If the device had been tested in a clinical trial it would have been clear that it was designed to fit a part of the spine the company wasn’t seeking approval for,” Diana Zuckerman of the National Center for Health Research explained to STAT.
Read More »PDUFA Again: Still Trying to Get It Right
MedPage Today, August 20, 2016: The Pharmaceutical Industry and some patient groups praised the latest drug user fee plan (PDUFA), but consumer advocates warned that drug safety is compromised when the focus is on faster approvals.
Read More »Ask the Expert: Is It Okay to Let My Toddler Use My iPad for Nursery Rhymes?
Irish Independent, August 17, 2016: You should not buy an iPad tablet for your toddler, because toddlers exposed to more screen time are more likely to face delays in learning, have poor sleep, develop behavior problems, and have weaker parent-child interactions. The article recommends the article on National Center for Health Research’s website.
Read More »Whistleblower Case Contends Surgical Device Maker Misled FDA — and Patients Paid the Price
STAT, August 15, 2016. Medtronic now faces a whistleblower lawsuit that claims it sought FDA approval for its devices under false pretenses. More scrutiny in a trial would have made it clear that the Medtronic device was sized to fit in the neck.
Read More »